Then, on January 14, 2025, ICON issued financial guidance for 2025 that came in well below analysts' expectations which the company attributed to the downturn in the industry. This news caused the ...

New York, New York-- (Newsfile Corp. - February 17, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against ICON plc (NASDAQ: ICLR) and certain ...

Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology ...

Non-U.S. developed markets stocks finished the fourth quarter lower. Political uncertainty in some of the largest European ...

Class A shares underperformed the MSCI ACWI ex USA Index. During the quarter, we initiated four new positions and exited one ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27, 2023 and ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

Erica Denhoff / Icon Sportswire via Getty Images Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech ...

Find Biotech Icons stock video, 4K footage, and other HD footage from iStock. Get higher quality Biotech Icons content, for less—All of our 4K video clips are the same price as HD. Video ...

Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...